Logo

OncoCyte

Oncocyte Switches Gears on Transplant Test Commercialization, Plans to Launch LDT Next Year
Premium

The company had previously planned to develop IVD kits for the US market but is now aiming to launch a lab-developed test in the second half of 2022.

Oncocyte Aims to Stand Out in Cancer Therapy Selection Market with 2022 Test Launches
Premium

The company will compete against established comprehensive genomic sequencing assays, but hopes to provide better immunotherapy prediction.

Oncocyte Posts $984K in Q3 Revenues, Misses Analyst Estimates

The company said its earnings were affected by impacts on lung cancer surgical volumes in its key sales regions as a result of the spread of the COVID-19 Delta variant.

People in the News: Collins to Depart NIH; Appointments at Oncocyte, Roswell Biotech; and More

Oncocyte Launches Prospective Registry to Drive DetermaRx Adoption, Improve Coverage
Premium

Through its real-world evidence registry, the firm hopes to further validate its NSCLC recurrence risk test as a tool for guiding adjuvant treatment.

Aug 11, 2021

Oncocyte Updates Plans for Chronix Transplant Tech; Will Develop and Market Kits in Europe
Premium

Aug 10, 2021

Oncocyte Sees $2M in Q2 Revenues, Beating Wall Street Estimate

Jun 15, 2021

EchelonDx, Oncocyte to Develop Software Supporting Commercial Diagnostics Expansion

Jun 14, 2021

Oncocyte Inks At-Market Agreement to Sell Up to $50M in Stock

Jun 3, 2021

Oncocyte, Italian Foundation to Investigate DetermaIO in Colorectal Cancer

May 17, 2021

Oncocyte Posts $1.1M in Q1 Revenues, Beating Wall Street Expectations

Apr 12, 2021

Oncocyte AACR Data Expands Potential Applications for Immunotherapy Response Predictor

Mar 18, 2021

Oncocyte Details New Expansions Plans With Growing Portfolio of Acquired Tests
Premium

Mar 16, 2021

Oncocyte Posts $503K in Q4 Revenues, Misses Wall Street Expectations

Mar 12, 2021

People in the News: New Appointments at Oncocyte, Ontera, Agilent, More

Feb 25, 2021

Oncocyte Closes Second and Final Investment in Razor Genomics Acquisition

Feb 5, 2021

Oncocyte to Raise $35M in Public Stock Offering

Feb 2, 2021

Oncocyte to Acquire Chronix Biomedical

Jan 20, 2021

Oncocyte to Raise $25M in Stock Sale to Institutional Investors

Dec 16, 2020

Piper Sandler Raises Rating on Oncocyte to Overweight

Dec 15, 2020

Burning Rock Biotech Licenses Oncocyte Lung Cancer Assay

Nov 30, 2020

BTIG Initiates Coverage of Oncocyte With Buy Rating

Nov 12, 2020

OncoCyte Posts $555K in Q3 Revenues, Net Loss Rises

Oct 21, 2020

Oncocyte DetermaRx Predicts Early Lung Cancer Outcomes Regardless of EGFR Status
Premium

Oct 8, 2020

Oncocyte, Fondazione Michelangelo to Evaluate DetermaIO Test for Immunotherapy Response Prediction

Breaking News
The Scan

University of Michigan President Fired

Mark Schlissel, the president of the University of Michigan, has been fired after an investigation into allegations he had an affair with a subordinate, the Washington Post reports.

Recommendation to Drop Charges

The Wall Street Journal says federal prosecutors recommended charges against MIT's Gang Chen, who was caught up by the China Initiative, be dropped.

Mix 'Em Together

The Guardian reports Moderna is planning to have a combination SARS-CoV-2, influenza, and RSV vaccine by the 2023 flu season.

PNAS Papers on Earth BioGenome Project, SETX Knockouts, Pig Model of Cystic Fibrosis

In PNAS this week: Earth BioGenome Project reports progress, analysis of cells missing the progressive neurodegenerative disease-linked SETX gene, and more.